Sriram Krishnan, Ph.D., Chief Product Officer at Target RWE; 20+ years building health tech, inventor on 28 patents, author of 30+ papers. As the chief product officer at Target RWE, a health ...
The path to bringing a new drug to market is increasingly complex and costly, with development costs now exceeding $2 billion and timelines approaching a decade. 1,2 The stakes have never been ...
Discover how biomedical science is entering a transformative new era, driven by advances in AI, genomics, and precision medicine.
Changes in the political climate of the United States are spilling into scientific research. While many past administrations, of both parties, supported and funded science funding and education, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results